US Edition
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of WTX-124 - Phoenix Bioscience Core
Summary by Phoenix Bioscience Core
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of WTX-124 - Phoenix Bioscience Core
Facebook Twitter LinkedIn Email Print There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening SCOTTSDALE, Ariz. — May 20, 2025 — A common and unsightly skin cancer that can turn deadly has been undetectable for more than a year in a patient treated with a new targeted immune-therapy in a clinical trial at HonorHealth Research Institute. Wayne Futch,…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
